Invention Grant
- Patent Title: Stabilized formulations of insulin that comprise ethylenediamine
- Patent Title (中): 包含乙二胺的胰岛素的稳定制剂
-
Application No.: US11914567Application Date: 2006-05-22
-
Publication No.: US08097584B2Publication Date: 2012-01-17
- Inventor: Christian Poulsen
- Applicant: Christian Poulsen
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Michael J. Brignati
- Priority: EP05104480 20050525
- International Application: PCT/EP2006/062491 WO 20060522
- International Announcement: WO2006/125763 WO 20061130
- Main IPC: A61K38/28
- IPC: A61K38/28 ; C07C211/00
Abstract:
The present invention relates to a pharmaceutical formulation comprising insulin, an insulin analogue or an insulin derivate and ethylenediamine or salts thereof and an antimicrobial preservative agent.
Public/Granted literature
- US20080267907A1 Stabilized Polypeptide Formulations Public/Granted day:2008-10-30
Information query
IPC分类:
